1887

Abstract

Infection with Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is linked strongly to development of KS, an endothelial neoplasm also characterized by striking neoangiogenesis and infiltration with inflammatory cells. To elucidate the links between endothelial infection and inflammation, primary human umbilical vein endothelial cells (HUVECs) were examined for the production of chemokines following latent KSHV infection. Several chemokines that are produced in the ground state, including MCP-1, NAP 2 and RANTES, are upregulated significantly by KSHV infection. Moreover, the chemokine CXCL16, which is nearly absent in uninfected cells, is induced significantly following infection. This induction is attributable primarily to expression of vFLIP, a known inducer of NF-B. CXCL16 induces the chemotaxis of activated T cells, whose products have been proposed to positively regulate KS tumour-cell survival and growth. Whilst CXCL16 has also been proposed as a direct endothelial chemoattractant and mitogen, neither proliferation nor chemotaxis of HUVECs was observed following CXCL16 exposure. These results suggest that CXCL16 induction by KSHV contributes to the inflammatory phenotype of KS, but plays little role in the recruitment of endothelial spindle cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82375-0
2007-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/1/46.html?itemId=/content/journal/jgv/10.1099/vir.0.82375-0&mimeType=html&fmt=ahah

References

  1. An J., Sun Y., Sun R., Rettig M. B. 2003; Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF- κ B and JNK/AP1 pathways. Oncogene 22:3371–3385 [CrossRef]
    [Google Scholar]
  2. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M. C., Cesarman E. 1997; Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347–350 [CrossRef]
    [Google Scholar]
  3. Boshoff C., Schulz T. F., Kennedy M. M., Graham A. K., Fisher C., Thomas A., McGee J. O., Weiss R. A., O'Leary J. J. 1995; Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1:1274–1278 [CrossRef]
    [Google Scholar]
  4. Chaudhary P. M., Jasmin A., Eby M. T., Hood L. 1999; Modulation of the NF- κ B pathway by virally encoded death effector domains-containing proteins. Oncogene 18:5738–5746 [CrossRef]
    [Google Scholar]
  5. Ciufo D. M., Cannon J. S., Poole L. J., Wu F. Y., Murray P., Ambinder R. F., Hayward G. S. 2001; Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 75:5614–5626 [CrossRef]
    [Google Scholar]
  6. Ensoli B., Stürzl M. 1998; Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9:63–83 [CrossRef]
    [Google Scholar]
  7. Ensoli B., Sgadari C., Barillari G., Sirianni M. C., Stürzl M., Monini P. 2001; Biology of Kaposi's sarcoma. Eur J Cancer 37:1251–1269 [CrossRef]
    [Google Scholar]
  8. Field N., Low W., Daniels M., Howell S., Daviet L., Boshoff C., Collins M. 2003; KSHV vFLIP binds to IKK- γ to activate IKK. J Cell Sci 116:3721–3728 [CrossRef]
    [Google Scholar]
  9. Glaunsinger B., Ganem D. 2004; Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J Exp Med 200:391–398 [CrossRef]
    [Google Scholar]
  10. Grossmann C., Podgrabinska S., Skobe M., Ganem D. 2006; Activation of NF- κ B by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80:7179–7185 [CrossRef]
    [Google Scholar]
  11. Liu L., Eby M. T., Rathore N., Sinha S. K., Kumar A., Chaudhary P. M. 2002; The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the I κ B kinase complex. J Biol Chem 277:13745–13751 [CrossRef]
    [Google Scholar]
  12. Ludwig A., Hundhausen C., Lambert M. H., Broadway N., Andrews R. C., Bickett D. M., Leesnitzer M. A., Becherer J. D. 2005; Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8:161–171 [CrossRef]
    [Google Scholar]
  13. Maral T. 2000; The Koebner phenomenon in immunosuppression-related Kaposi's sarcoma. Ann Plast Surg 44:646–648 [CrossRef]
    [Google Scholar]
  14. Matloubian M., David A., Engel S., Ryan J. E., Cyster J. G. 2000; A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298–304 [CrossRef]
    [Google Scholar]
  15. Matta H., Chaudhary P. M. 2004; Activation of alternative NF- κ B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 β -converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101:9399–9404 [CrossRef]
    [Google Scholar]
  16. Moore P. S., Boshoff C., Weiss R. A., Chang Y. 1996; Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–1744 [CrossRef]
    [Google Scholar]
  17. Nakamura S., Salahuddin S. Z., Biberfeld P., Ensoli B., Markham P. D., Wong-Staal F., Gallo R. C. 1988; Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science 242:426–430 [CrossRef]
    [Google Scholar]
  18. Nicholas J. 2005; Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25:373–383 [CrossRef]
    [Google Scholar]
  19. Nicholas J., Ruvolo V. R., Burns W. H., Sandford G., Wan X., Ciufo D., Hendrickson S. B., Guo H.-G., Hayward G. S., Reitz M. S. 1997; Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287–292 [CrossRef]
    [Google Scholar]
  20. Oksenhendler E., Carcelain G., Aoki Y., Boulanger E., Maillard A., Clauvel J.-P., Agbalika F. 2000; High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96:2069–2073
    [Google Scholar]
  21. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. 2000; Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743–749 [CrossRef]
    [Google Scholar]
  22. Schulz T. F. 1999; Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 76:121–160
    [Google Scholar]
  23. Staskus K. A., Sun R., Miller G., Racz P., Jaslowski A., Metroka C., Brett-Smith H., Haase A. T. 1999; Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73:4181–4187
    [Google Scholar]
  24. Sun Q., Matta H., Chaudhary P. M. 2003a; The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF- κ B activation. Blood 101:1956–1961 [CrossRef]
    [Google Scholar]
  25. Sun Q., Zachariah S., Chaudhary P. M. 2003b; The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF- κ B activation. J Biol Chem 278:52437–52445 [CrossRef]
    [Google Scholar]
  26. Sun Q., Matta H., Chaudhary P. M. 2005; Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 long terminal repeat via the classical NF- κ B pathway and functionally cooperates with Tat. Retrovirology 2:9 [CrossRef]
    [Google Scholar]
  27. Sun Q., Matta H., Lu G., Chaudhary P. M. 2006; Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF- κ B activation. Oncogene 25:2717–2726 [CrossRef]
    [Google Scholar]
  28. Wang H.-W., Trotter M. W. B., Lagos D., Bourboulia D., Henderson S., Mäkinen T., Elliman S., Flanagan A. M., Alitalo K., Boshoff C. 2004; Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36:687–693 [CrossRef]
    [Google Scholar]
  29. Zhou F.-C., Zhang Y.-J., Deng J.-H., Wang X.-P., Pan H.-Y., Hettler E., Gao S.-J. 2002; Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76:6185–6196 [CrossRef]
    [Google Scholar]
  30. Zhuge X., Murayama T., Arai H., Yamauchi R., Tanaka M., Shimaoka T., Yonehara S., Kume N., Yokode M., Kita T. 2005; CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem Biophys Res Commun 331:1295–1300 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82375-0
Loading
/content/journal/jgv/10.1099/vir.0.82375-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error